Targanta Therapeutics Corporation was created in 1997.
Targanta Therapeutics Corporation's population is 1,398,161.
The population of Targanta Therapeutics Corporation is 1.
The symbol for United Therapeutics Corporation in NASDAQ is: UTHR.
United Therapeutics Corporation (UTHR) had its IPO in 1999.
As of July 2014, the market cap for United Therapeutics Corporation (UTHR) is $4,429,004,268.71.
Halozyme Therapeutics was created in 1998.
Silence Therapeutics was created in 1994.
Acorda Therapeutics was created in 1995.
IL Therapeutics was created in 2005.
Edge Therapeutics was created in 2009.
TauRx Therapeutics was created in 2002.
Prime Therapeutics was created in 1998.